Testing effectiveness (Phase 2)Study completedNCT01378975What this trial is testingVemurafenib in Metastatic Melanoma Participants With Brain MetastasesWho this might be right forMalignant Melanoma Hoffmann-La Roche 146
Testing effectiveness (Phase 2)Study completedNCT00563823What this trial is testingVatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by SurgeryWho this might be right forMelanoma (Skin) Cambridge University Hospitals NHS Foundation Trust 34
Testing effectiveness (Phase 2)Study completedNCT02379195What this trial is testingPeginterferon and TIL Therapy for Metastatic MelanomaWho this might be right forMetastatic Melanoma Inge Marie Svane 12
Early research (Phase 1)Study completedNCT02858869What this trial is testingPembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain MetastasesWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more Emory University 25
Testing effectiveness (Phase 2)Ended earlyNCT01369875What this trial is testingModified Tumor Infiltrating Lymphocytes for Metastatic MelanomaWho this might be right forMetastatic MelanomaSkin Cancer National Cancer Institute (NCI) 2
Early research (Phase 1)Study completedNCT00014456What this trial is testingCombination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsWho this might be right forBladder CancerBreast CancerCarcinoma of Unknown Primary+9 more Dartmouth-Hitchcock Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00001705What this trial is testingImmunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal SequenceWho this might be right forMelanomaNeoplasm Metastasis National Cancer Institute (NCI) 141
Testing effectiveness (Phase 2)Study completedNCT01827111What this trial is testingPhase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00436930What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic MelanomaWho this might be right forMelanoma (Skin) Hoag Memorial Hospital Presbyterian 200
Not applicableStudy completedNCT02133222What this trial is testingCirculating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After ChemotherapyWho this might be right forMetastatic (Stage IV) Melanoma Centre Hospitalier Universitaire de Nice 22
Early research (Phase 1)Looking for participantsNCT07027488What this trial is testingAB821 in Adult Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Melanoma and Normal or ImpairedAdvanced Melanoma Yale University 50
Testing effectiveness (Phase 2)Study completedNCT00002786What this trial is testingBiological Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Fred Hutchinson Cancer Center 20
Not applicableStudy completedNCT06369428What this trial is testingPatient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma PatientsWho this might be right forMetastatic Melanoma Novartis 1,795
Testing effectiveness (Phase 2)WithdrawnNCT05561491What this trial is testingONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma PatientsWho this might be right forMelanoma Targovax Oy
Testing effectiveness (Phase 2)Looking for participantsNCT07504796What this trial is testingCtDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and RelatlimabWho this might be right forMetastatic MelanomaAdvanced Melanoma NYU Langone Health 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03474497What this trial is testingUCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint BlockadeWho this might be right forNon Small Cell Lung CancerMetastatic MelanomaMetastatic Renal Cell Carcinoma+1 more Megan Daly, MD 18
Testing effectiveness (Phase 2)Study completedNCT00066196What this trial is testingEvaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic MelanomaWho this might be right forMelanomaMalignant Metastatic Melanoma MedImmune LLC 110
Early research (Phase 1)Study completedNCT01295827What this trial is testingStudy of Pembrolizumab (MK-3475) in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)Who this might be right forCancer, Solid Tumor Merck Sharp & Dohme LLC 1,260
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00256282What this trial is testingDocetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant MelanomaWho this might be right forMetastatic Melanoma John P. Fruehauf 52